This inventor holds 1 USPTO granted patent. Top assignee: Sanofi. Active years: 1995.
Company Filing History:
Years Active: 1995
Title: Thierry Maureaud: Innovator in Pharmaceutical Development
Introduction
Thierry Maureaud is a notable inventor based in Auzielle, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug formulations. His work has led to advancements that may improve therapeutic options for patients.
Latest Patents
Thierry Maureaud holds a patent for "Drugs containing a glycosylated interleukin-2." This patent describes an interleukin-2 preparation suitable for pharmaceutical purposes, consisting essentially of disialilated glycosylated interleukin-2, monosialilated glycosylated interleukin-2, or a mixture thereof. The preparation is substantially free of organic solvents and is isolated from recombinant CHO cells transformed with a vector containing a DNA sequence coding for a natural precursor of human interleukin-2. The purification process involves a multi-step method, ensuring the quality and efficacy of the drug.
Career Highlights
Thierry Maureaud is associated with Sanofi, a leading global healthcare company. His work at Sanofi has allowed him to contribute to the development of innovative pharmaceutical solutions. His expertise in glycosylated interleukin-2 has positioned him as a key figure in the field of drug development.
Collaborations
Throughout his career, Thierry has collaborated with notable professionals, including Willem Roskam, who is deceased, and Natalio Vita. These collaborations have enriched his research and contributed to the advancement of pharmaceutical innovations.
Conclusion
Thierry Maureaud's contributions to the pharmaceutical industry, particularly through his patent on glycosylated interleukin-2, highlight his role as an innovator in drug development. His work continues to influence the field and offers promising therapeutic options for patients.